Respiratory system

Farmak International supplies European hospitals with essential respiratory system medications and products for asthma, COPD, and acute respiratory infections. As a bronchodilator supplier hospitals rely on, we provide inhalers, nebulizer solutions, and oral therapies supporting pulmonology departments and emergency care.

Respiratory System Product Portfolio

In our catalog, you’ll find anti-inflammatory respiratory drugs for inhalation, including budesonide unit-dose suspension for inhalation. For airway opening in asthma and COPD pathways, we support bronchodilator procurement with fenoterol + ipratropium inhalation solutions, as well as ipratropium bromide solutions for inhalations.

The same respiratory treatment set for mucus clearance and cough pathways often includes mucolytics and expectorants (acetylcysteine unit-dose sachets, ambroxol syrup, and ambroxol-based combinations). Acute cough support includes butamirate citrate + guaiphenesin oral drops for outpatient symptom control.

Institutional Supply Applications

We supply four respiratory lines for different purposes:

Each item comes with a release form, strength, primary packaging, status, and dossier type, so formulary decisions remain traceable and maintain respiratory care continuity.

Product Specifications & Formulations

Pulmonary health products are supplied in unit-dose and container formats to support nebulization rooms and ward stock control.

Oral lines (capsules, syrups, sachets, drops) and nasal options used in allergy medications procurement allow step-down care without confusing substitutions. Where pediatric and adult strengths both exist, they are kept as separate items by strength and packed to match local dispensing rules.

Storage and transport follow the locally approved label; our supply-chain team runs GDP-compliant warehousing, manages country-specific labeling and multilingual patient information, and maintains cold chain requirements when necessary, using qualified forwarding partners and route planning aligned to GDP expectations.

Regulatory Compliance & Quality Assurance

Farmak International maintains a quality system supported by national authority, World Health Organization audits, and a management framework aligned with recognized ISO standards.

We protect anti-inflammatory respiratory drugs and chronic respiratory disorder medications with consistent batch quality:

Our pharmacovigilance processes support pulmonary health products distributor reviews and align with EU reporting requirements for respiratory therapies.

Farmak’s Role as a Trusted B2B Supplier of Respiratory Medications

Farmak International supports Europe-wide partners as a respiratory infection treatment medications supplier, with tender-ready documentation. If you are qualifying a bronchodilator supplier hospitals rely on, start with the shortlist in our catalog and share your target country and annual volume so we can confirm dossier format, lead times, and handling requirements for your purchasing pathway.